KAIROS PHARMA, LTD. Amortization of Deferred Charges
KAIROS PHARMA, LTD. (KAPA) reported Amortization of Deferred Charges of $18.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2026-08-12
- KAIROS PHARMA, LTD. amortization of deferred charges for the quarter ending 2026-06-30 was $0.00.
- KAIROS PHARMA, LTD. amortization of deferred charges for the quarter ending 2026-03-31 was $18.00K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $18.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |